Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018128510) COMPOSITION FOR PREVENTING OR TREATING METASTATIC OVARIAN CANCER, ENDOMETRIAL CANCER OR BREAST CANCER
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/128510 International Application No.: PCT/KR2018/000379
Publication Date: 12.07.2018 International Filing Date: 08.01.2018
IPC:
A61K 31/506 (2006.01) ,A61K 31/496 (2006.01) ,A61K 31/155 (2006.01) ,A23L 33/10 (2016.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
495
having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
506
not condensed and containing further heterocyclic rings
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
495
having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
496
Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
13
Amines, e.g. amantadine
155
Amidines (), e.g. guanidine (H2N-C(NH)-NH2), isourea (HNC(OH)NH2), isothiourea (HNC(SH)-NH2)
[IPC code unknown for A23L 33/10]
Applicants:
주식회사 레모넥스 LEMONEX INC. [KR/KR]; 서울시 관악구 관악로 1, 서울대학교 (신림동) (Sillim-dong) Seoul National University, 1, Gwanak-ro, Gwanak-gu, Seoul 08826, KR
Inventors:
이재호 LEE, Jae Ho; KR
민달희 MIN, Dal Hee; KR
원철희 WON, Cheol Hee; KR
Agent:
두호특허법인 DOOHO IP LAW FIRM; 서울시 서초구 강남대로 51길 1, 7층 (서초동, 대현블루타워) (Daehyun Blue Tower, Seocho-dong) 7th Floor, 1, Gangnam-daero 51-gil, Seocho-gu, Seoul 06628, KR
Priority Data:
10-2017-000218006.01.2017KR
10-2018-000249108.01.2018KR
Title (EN) COMPOSITION FOR PREVENTING OR TREATING METASTATIC OVARIAN CANCER, ENDOMETRIAL CANCER OR BREAST CANCER
(FR) COMPOSITION POUR LA PRÉVENTION OU LE TRAITEMENT DU CANCER MÉTASTATIQUE DE L'OVAIRE, LE CANCER DE L'ENDOMÈTRE OU LE CANCER DU SEIN
(KO) 전이성 난소암, 자궁내막암 또는 유방암의 예방 또는 치료용 조성물
Abstract:
(EN) The present invention relates to a pharmaceutical composition for preventing or treating metastatic ovarian cancer, endometrial cancer or breast cancer which comprises a compound of chemical formula 1 or a pharmaceutically acceptable salt thereof.
(FR) La présente invention concerne une composition pharmaceutique pour la prévention ou le traitement du cancer métastatique de l'ovaire, le cancer de l'endomètre ou le cancer du sein, qui comprend un composé représenté par la formule chimique 1 ou un sel pharmaceutiquement acceptable de celui-ci.
(KO) 본 발명은 화학식 1의 화합물 또는 이의 약학적으로 허용가능한 염을 포함하는 전이성 난소암, 자궁내막암 또는 유방암의 예방 또는 치료용 약학적 조성물에 관한 것이다.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Korean (KO)
Filing Language: Korean (KO)